Protective Effects of Glucose-Related Protein 78 and 94 on Cisplatin-Mediated Ototoxicity

Cisplatin is a widely used chemotherapeutic drug for treating various solid tumors. Ototoxicity is a major dose-limiting side effect of cisplatin, which causes progressive and irreversible sensorineural hearing loss. Here, we examined the protective effects of glucose-related protein (GRP) 78 and 94...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Junyeong, Kim, Tae Su, Pak, Jhang Ho, Chung, Jong Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465420/
https://www.ncbi.nlm.nih.gov/pubmed/32748834
http://dx.doi.org/10.3390/antiox9080686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465420/
https://www.ncbi.nlm.nih.gov/pubmed/32748834
http://dx.doi.org/10.3390/antiox9080686

Ejemplares similares